<DOC>
	<DOC>NCT00909870</DOC>
	<brief_summary>This study randomly assigns patients with venous leg ulcers to receive standard therapy (compression) alone or compression plus Dermagraft(R). Dermagraft is a device containing live human fibroblasts grown on an absorbable Vicryl mesh. Patients are seen weekly until they heal or the 16-week treatment period is complete. Follow-up visits are conducted monthly for three months in order to assess patients for longer term safety.</brief_summary>
	<brief_title>Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>&gt;18 years of age ABI &gt; 0.80 Three or fewer venous leg ulcers, if multiple must be separated by 2 cm Ultrasound demonstrates venous reflux &gt;0.5 seconds Study wound present for 124 months Study wound 215 sq cm surface area Clean, granulating wound Patient able and willing to sign informed consent and comply with study procedures. Women of childbearing potential must use birth control pills, barriers or abstinence and have a negative pregnancy test. Wound etiology uncertain or not from venous hypertension. BMI&gt;40 Acute or chronic infectious skin disease Allergy or intolerance to Profore(R) Wound infection, cellulitis, osteomyelitis &gt;2 weeks' treatment with immunosuppressive agents in recent past Investigational drug use within 30 days Severe malnutrition, drug and/or alcohol abuse Malignant disease unless in remission for 5 years History of radiation at the study site Other conditions that could impede wound healing Known history of HIV or AIDS Prior participation in any Dermagraft study Treatment with other bioengineered tissue products within 30 days Unable to understand the aims and objectives of the trial Inability to comply with study protocol NYHA Class III or IV CHF Uncontrolled diabetes mellitus Dorsal foot ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Venous leg ulcer</keyword>
	<keyword>randomized trial</keyword>
	<keyword>clinical trial</keyword>
	<keyword>Dermagraft</keyword>
	<keyword>compression therapy</keyword>
	<keyword>surgical debridement</keyword>
	<keyword>venous stasis</keyword>
	<keyword>chronic ulcer</keyword>
	<keyword>chronic wound</keyword>
	<keyword>fibroblasts</keyword>
</DOC>